サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1786974

在宅輸液療法の世界市場：規模、シェア、動向、産業分析レポート：タイプ別、用途別、地域別 - 市場予測（2025年～2034年）

Home Infusion Therapy Market Size, Share, Trend, Industry Analysis Report By Type, By Application, By Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 129 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.69円
在宅輸液療法の世界市場：規模、シェア、動向、産業分析レポート：タイプ別、用途別、地域別 - 市場予測（2025年～2034年）
出版日: 2025年07月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、在宅輸液療法の市場規模は2034年までに833億1,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

在宅輸液療法市場とは、病院や輸液センターではなく、患者の自宅において静脈内または皮下ルートで薬剤を投与することを指します。このアプローチは患者の利便性を高め、ヘルスケアコストを削減し、院内感染のリスクを軽減します。がん、免疫不全、胃腸障害などの慢性疾患の増加により、代替となる選択肢としての在宅治療への需要が加速しています。支払者やヘルスケアシステムは、入院コストの上昇を抑えるために外来や在宅ケアモデルを推進しており、従来の臨床環境以外で提供される輸液サービスの採用を強化しています。また、コンパクトで使いやすい輸液ポンプや、遠隔モニタリングやバーチャルケアの統合を可能にするデジタルヘルスツールの開発も、市場の成長を支えています。

慢性疾患管理用に調整された生物製剤や特殊薬剤の継続的な進歩は、信頼性の高い在宅輸液プロトコルの必要性を高めています。医師による受け入れと償還の明確性が大幅に改善され、より幅広い患者への適用が可能になりました。製薬会社とサービスプロバイダーは、ドラッグデリバリーと継続的なケアマネジメントをバンドルし、患者のアドヒアランスと治療成果を高めるために、価値ベースのパートナーシップを結んでいます。在宅輸液療法市場は、患者中心のロジスティクスと教育を活用したサービスの個別化にますます焦点が当てられています。

臨床的に輸液が必要とされ、頻繁な通院が負担となるホルモン療法、疼痛管理、希少疾患治療など、拡大する治療領域に治療機会が存在します。遠隔医療と自動文書化システムの統合は業務効率を一変させ、医療提供者はケアの質を維持しながら大量の患者を管理できるようになります。在宅輸液は、長期ケア戦略や分散型ヘルスケア提供の重要な要素として進化を続けています。

在宅輸液療法市場レポートのハイライト

タイプ別では、在宅環境における熟練看護師、薬局支援、現場管理の専門知識に対するニーズの高まりから、2024年の収益シェアはサービスセグメントが72%を占めました。

用途別では、外来患者における骨髄炎、蜂巣炎、心内膜炎などの感染症を治療するために抗生物質の静脈内投与が広く使用されていることから、2024年には抗感染症セグメントが最大の売上シェアを占めました。

北米は、強固なヘルスケアインフラ、保険の普及、長期療養を必要とする高齢化により、2024年の在宅輸液療法市場の売上高の57%を占めました。

アジア太平洋市場は、ヘルスケア意識の高まり、都市化、医療の分散化の取り組みにより、2025年～2034年に大きく成長すると予想されています。

世界の主要企業には、Amedisys, Inc.、B. Braun SE、Baxter、BD、CareCentrix, Inc.、Coram LLC.、Fresenius Kabi AG、ICU Medical, Inc.、JMS Co.Ltd.、Moog Inc.、Option Care Health, Inc.、PharMerica Corporation、Terumo Corporationなどがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の在宅輸液療法市場の洞察

  • 市場スナップショット
  • 在宅輸液療法市場力学
    • 促進要因と機会
      • 慢性疾患の有病率の上昇
      • 長期治療を必要とする高齢化社会
    • 抑制要因と課題
      • 輸液装置の高コスト
  • PESTEL分析
  • 在宅輸液療法市場の用途動向
  • バリューチェーン分析

第5章 世界の在宅輸液療法市場：タイプ別

  • 主な調査結果
  • イントロダクション
  • 製品
  • サービス

第6章 世界の在宅輸液療法市場：用途別

  • 主な調査結果
  • イントロダクション
  • 抗感染症
  • 内分泌学
  • 水分補給療法
  • 化学療法
  • 経腸栄養
  • 静脈栄養
  • 専門医薬品
  • その他

第7章 世界の在宅輸液療法市場：地域別

  • 主な調査結果
  • イントロダクション
    • 在宅輸液療法市場の評価：地域別、2020～2034年
  • 北米
    • 北米：タイプ別、2020～2034年
    • 北米：用途別、2020～2034年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州：タイプ別、2020～2034年
    • 欧州：用途別、2020～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：タイプ別、2020～2034年
    • アジア太平洋：用途別、2020～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：タイプ別、2020～2034年
    • 中東・アフリカ：用途別、2020～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：タイプ別、2020～2034年
    • ラテンアメリカ：用途別、2020～2034年
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第8章 競合情勢

  • 事業拡大・買収分析
    • 事業拡大
    • 買収
  • 提携/協業/協定/公開

第9章 企業プロファイル

  • Amedisys, Inc.
  • B. Braun SE.
  • Baxter
  • BD
  • CareCentrix, Inc.
  • Coram LLC.
  • Fresenius Kabi AG
  • ICU Medical, Inc.
  • JMS Co. Ltd.
  • Moog Inc.
  • Option Care Health, Inc.
  • PharMerica Corporation
  • Terumo Corporation
図表

List of Tables:

  • Table 1 Global Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 3 North America: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 4 North America: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 5 U.S.: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 6 U.S.: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 7 Canada: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 8 Canada: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 9 Mexico: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 10 Mexico: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 11 Europe: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 12 Europe: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 13 UK: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 14 UK: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 15 France: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 16 France: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 17 Germany: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 18 Germany: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 19 Italy: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 20 Italy: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 21 Spain: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 22 Spain: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 23 Netherlands: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 24 Netherlands: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 25 Russia: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Russia: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Rest of Europe: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 28 Rest of Europe: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 29 Asia Pacific: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 30 Asia Pacific: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 31 China: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 32 China: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 33 India: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 34 India: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 35 Malaysia: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 36 Malaysia: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 37 Japan: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Japan: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Indonesia: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 40 Indonesia: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 41 South Korea: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 42 South Korea: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 43 Australia: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 44 Australia: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 45 Rest of Asia Pacific: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 46 Rest of Asia Pacific: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 47 Middle East & Africa: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 48 Middle East & Africa: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 49 Saudi Arabia: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Saudi Arabia: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 51 UAE: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 52 UAE: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 53 Israel: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 54 Israel: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 55 South Africa: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 56 South Africa: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Rest of Middle East & Africa: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 58 Rest of Middle East & Africa: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 59 Latin America: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 60 Latin America: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 61 Brazil: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Brazil: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Argentina: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 64 Argentina: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Home Infusion Therapy Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Home Infusion Therapy Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Home Infusion Therapy Market, by Application, 2024 & 2034 (USD Billion)
目次
Product Code: PM5987

The home infusion therapy market size is expected to reach USD 83.31 billion by 2034, according to a new study by Polaris Market Research. The report "Home Infusion Therapy Market Size, Share, Trend, Industry Analysis Report By Type (Product, Service), By Application (Anti-infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition), By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The home infusion therapy market refers to the administration of medications through intravenous or subcutaneous routes in a patient's home setting, rather than in hospitals or infusion centers. This approach supports patient convenience, lowers healthcare costs, and reduces hospital-acquired infection risks. The increasing prevalence of chronic diseases such as cancer, immune deficiencies, and gastrointestinal disorders has accelerated demand for home-based treatment alternatives. Payers and healthcare systems are pushing for outpatient and home care models to curb rising inpatient costs, reinforcing adoption of infusion services delivered outside traditional clinical settings. The market growth is also supported by the development of compact, user-friendly infusion pumps and digital health tools that enable remote monitoring and virtual care integration.

Ongoing advancements in biologics and specialty drugs tailored for chronic disease management boost the need for reliable home infusion protocols. Physician acceptance and reimbursement clarity have significantly improved, enabling broader patient eligibility. Pharmaceutical companies and service providers are forming value-based partnerships to bundle drug delivery with ongoing care management, enhancing patient adherence and therapeutic outcomes. The home infusion therapy market is witnessing increased focus on service personalization, leveraging patient-centric logistics and education.

Opportunities exist in expanding therapeutic areas, including hormonal therapies, pain management, and rare disease treatments, where infusion is clinically required and frequent hospital visits are burdensome. The integration of telehealth and automated documentation systems is transforming operational efficiency, allowing providers to manage high patient volumes while maintaining care quality. Home infusion continues to evolve as a key component in long-term care strategies and decentralized healthcare delivery.

Home Infusion Therapy Market Report Highlights

By type, the service segment accounted for ~72% of the revenue share in 2024, due to the growing need for skilled nursing, pharmacy support, and on-site administration expertise in home settings.

Based on application, the anti-infective segment accounted for the largest revenue share in 2024, due to the widespread use of intravenous antibiotics to treat infections such as osteomyelitis, cellulitis, and endocarditis in outpatient settings.

North America accounted for ~57% share of the home infusion therapy market revenue in 2024 due to strong healthcare infrastructure, widespread insurance coverage, and an aging population requiring long-term care.

The Asia Pacific market is expected to grow significantly from 2025 to 2034 due to rising healthcare awareness, urbanization, and efforts to decentralize medical care.

A few global key players include Amedisys, Inc.; B. Braun SE; Baxter; BD; CareCentrix, Inc.; Coram LLC.; Fresenius Kabi AG; ICU Medical, Inc.; JMS Co. Ltd.; Moog Inc.; Option Care Health, Inc.; PharMerica Corporation; and Terumo Corporation.

Polaris Market Research has segmented the home infusion therapy market on the basis of type, application, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Product

Infusion Pumps

Elastomeric

Electromechanical

Gravity

Others

Intravenous Sets

IV Cannulas

Needleless Connectors

Services

By Application Outlook (Revenue, USD Billion, 2020-2034)

Anti-Infective

Endocrinology

Diabetes

Others

Hydration Therapy

Chemotherapy

Enteral Nutrition

Parenteral Nutrition

Specialty Pharmaceuticals

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Home Infusion Therapy Market Insights

  • 4.1. Home Infusion Therapy Market - Market Snapshot
  • 4.2. Home Infusion Therapy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Chronic Diseases
      • 4.2.1.2. Aging Population Requiring Long-Term Therapy
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High costs of infusion equipment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Home Infusion Therapy Market Application Trends
  • 4.6. Value Chain Analysis

5. Global Home Infusion Therapy Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Product
    • 5.3.1. Global Home Infusion Therapy Market, by Product, by Region, 2020-2034 (USD Billion)
    • 5.3.2. Infusion Pumps
      • 5.3.2.1. Global Home Infusion Therapy Market, by Infusion Pumps, by Region, 2020-2034 (USD Billion)
      • 5.3.2.2. Elastomeric
      • 5.3.2.2.1. Global Home Infusion Therapy Market, by Elastomeric, by Region, 2020-2034 (USD Billion)
      • 5.3.2.3. Electromechanical
      • 5.3.2.3.1. Global Home Infusion Therapy Market, by Electromechanical, by Region, 2020-2034 (USD Billion)
      • 5.3.2.4. Gravity
      • 5.3.2.4.1. Global Home Infusion Therapy Market, by Gravity, by Region, 2020-2034 (USD Billion)
      • 5.3.2.5. Others
      • 5.3.2.5.1. Global Home Infusion Therapy Market, by Others, by Region, 2020-2034 (USD Billion)
    • 5.3.3. Intravenous Sets
      • 5.3.3.1. Global Home Infusion Therapy Market, by Home Infusion Therapy Therapeutics, by Region, 2020-2034 (USD Billion)
    • 5.3.4. IV Cannulas
      • 5.3.4.1. Global Home Infusion Therapy Market, by IV Cannulas, by Region, 2020-2034 (USD Billion)
    • 5.3.5. Needleless Connectors
      • 5.3.5.1. Global Home Infusion Therapy Market, by Needleless Connectors, by Region, 2020-2034 (USD Billion)
  • 5.4. Services
    • 5.4.1. Global Home Infusion Therapy Market, by Personalized Medical Care, by Region, 2020-2034 (USD Billion)

6. Global Home Infusion Therapy Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Anti-Infective
    • 6.3.1. Global Home Infusion Therapy Market, by Anti-Infective, by Region, 2020-2034 (USD Billion)
  • 6.4. Endocrinology
    • 6.4.1. Global Home Infusion Therapy Market, by Endocrinology, by Region, 2020-2034 (USD Billion)
    • 6.4.2. Diabetes
      • 6.4.2.1. Global Home Infusion Therapy Market, by Diabetes, by Region, 2020-2034 (USD Billion)
    • 6.4.3. Others
      • 6.4.3.1. Global Home Infusion Therapy Market, by Others, by Region, 2020-2034 (USD Billion)
  • 6.5. Hydration Therapy
    • 6.5.1. Global Home Infusion Therapy Market, by Hydration Therapy, by Region, 2020-2034 (USD Billion)
  • 6.6. Chemotherapy
    • 6.6.1. Global Home Infusion Therapy Market, by Chemotherapy, by Region, 2020-2034 (USD Billion)
  • 6.7. Enteral Nutrition
    • 6.7.1. Global Home Infusion Therapy Market, by Enteral Nutrition, by Region, 2020-2034 (USD Billion)
  • 6.8. Parenteral Nutrition
    • 6.8.1. Global Home Infusion Therapy Market, by Parenteral Nutrition, by Region, 2020-2034 (USD Billion)
  • 6.9. Specialty Pharmaceuticals
    • 6.9.1. Global Home Infusion Therapy Market, by Specialty Pharmaceuticals, by Region, 2020-2034 (USD Billion)
  • 6.10. Others
    • 6.10.1. Global Home Infusion Therapy Market, by Othersr, by Region, 2020-2034 (USD Billion)

7. Global Home Infusion Therapy Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Home Infusion Therapy Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Home Infusion Therapy Market - North America
    • 7.3.1. North America: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
    • 7.3.2. North America: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.3.3. Home Infusion Therapy Market - U.S.
      • 7.3.3.1. U.S.: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.3.4. Home Infusion Therapy Market - Canada
      • 7.3.4.1. Canada: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.3.5. Home Infusion Therapy Market - Mexico
      • 7.3.5.1. Mexico: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.3.5.2. Mexico: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • 7.4. Home Infusion Therapy Market - Europe
    • 7.4.1. Europe: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.4.3. Home Infusion Therapy Market - UK
      • 7.4.3.1. UK: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.4.4. Home Infusion Therapy Market - France
      • 7.4.4.1. France: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.4.5. Home Infusion Therapy Market - Germany
      • 7.4.5.1. Germany: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.4.6. Home Infusion Therapy Market - Italy
      • 7.4.6.1. Italy: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.4.7. Home Infusion Therapy Market - Spain
      • 7.4.7.1. Spain: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.4.8. Home Infusion Therapy Market - Netherlands
      • 7.4.8.1. Netherlands: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.4.9. Home Infusion Therapy Market - Russia
      • 7.4.9.1. Russia: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.4.10. Home Infusion Therapy Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • 7.5. Home Infusion Therapy Market - Asia Pacific
    • 7.5.1. Asia Pacific: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.5.3. Home Infusion Therapy Market - China
      • 7.5.3.1. China: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.5.4. Home Infusion Therapy Market - India
      • 7.5.4.1. India: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.5.5. Home Infusion Therapy Market - Malaysia
      • 7.5.5.1. Malaysia: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.5.6. Home Infusion Therapy Market - Japan
      • 7.5.6.1. Japan: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.5.7. Home Infusion Therapy Market - Indonesia
      • 7.5.7.1. Indonesia: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.5.8. Home Infusion Therapy Market - South Korea
      • 7.5.8.1. South Korea: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.5.9. Home Infusion Therapy Market - Australia
      • 7.5.9.1. Australia: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.5.10. Home Infusion Therapy Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • 7.6. Home Infusion Therapy Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.6.3. Home Infusion Therapy Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.6.4. Home Infusion Therapy Market - UAE
      • 7.6.4.1. UAE: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.6.5. Home Infusion Therapy Market - Israel
      • 7.6.5.1. Israel: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.6.6. Home Infusion Therapy Market - South Africa
      • 7.6.6.1. South Africa: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.6.7. Home Infusion Therapy Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
  • 7.7. Home Infusion Therapy Market - Latin America
    • 7.7.1. Latin America: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.7.3. Home Infusion Therapy Market - Brazil
      • 7.7.3.1. Brazil: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.7.3.2. Brazil: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.7.4. Home Infusion Therapy Market - Argentina
      • 7.7.4.1. Argentina: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.7.4.2. Argentina: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)
    • 7.7.5. Home Infusion Therapy Market - Rest of Latin America
      • 7.7.5.1. Rest of Latin America: Home Infusion Therapy Market, by Type, 2020-2034 (USD Billion)
      • 7.7.5.2. Rest of Latin America: Home Infusion Therapy Market, by Application, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Amedisys, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. B. Braun SE.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Baxter
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. BD
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. CareCentrix, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Coram LLC.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Fresenius Kabi AG
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. ICU Medical, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. JMS Co. Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Moog Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Option Care Health, Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. PharMerica Corporation
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Terumo Corporation
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development